BRIEF-Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
ReutersFeb 5, 2025 12:36 PM
Feb 5 (Reuters) - Adicet Bio Inc ACET.O:
ADICET BIO RECEIVES FDA FAST TRACK DESIGNATION FOR ADI-001 FOR THE TREATMENT OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) WITH EXTRARENAL INVOLVEMENT
Source text: ID:nBw6rbxg5a
Further company coverage: ACET.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Powell's Jackson Hole Speech: For U.S. Stocks, Hawk or Dove Signal Could Be a Lose-Lose?
TradingKey - As U.S. inflation and labor market data show signs of rebalancing, Treasury traders and Wall Street banks have largely priced in a rate cut at the September FOMC meeting — the first of 2025. Yet both a more dovish-than-expected tone and a potential surprise hawkish signal from Fed ChairTradingKey
Mon, Aug 18
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
Global Crypto Treasury Boom: Which Companies and Tokens Are Becoming Investor Favorites?
A Crypto Treasury refers to a company allocating idle or raised capital to purchase cryptocurrencies, integrating them into its balance sheet as reserve assets or yield-generating tools.TradingKey
Wed, Jul 30
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,TradingKey
Wed, Jul 23
Japanese Stocks: Strategic Differences Between Short-Term and Long-Term Approaches
TradingKey - Following significant gains in 2023 and 2024, we anticipate that the Japanese stock market will enter a period of volatility and consolidation. This outlook stems from two opposing forces. On the positive side, Japan's improving economic fundamentals are driving wage growth and...TradingKey
Wed, Jul 23
